Inotek Pharmaceuticals Corp (ITEK): Billionaire Ken Griffin’ Citadel Investment Group Raises Stake to 6.5%

Page 9 of 10

Page 9 of 10 – SEC Filing
C. Citadel GP LLC and Kenneth Griffin
(a) CGP and Griffin may be deemed to beneficially own 1,875,432 shares of common stock.
(b) The number of shares CGP and Griffin may be deemed to beneficially own constitutes approximately 6.5%
of the common stock outstanding.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 1,875,432
(iii) sole power to dispose or to direct the disposition of: 0
(iv) shared power to dispose or to direct the disposition of: 1,875,432
Item 5 Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than 5 percent of the class of securities, check the following ¨.

 

Item 6 Ownership of More than Five Percent on Behalf of Another
Person
Not Applicable

 

Item 7 Identification and Classification of the Subsidiary
which Acquired the Security Being Reported on by the Parent Holding Company
See Item 2 above

 

Item 8 Identification and Classification of Members of the
Group
Not Applicable
Item 9 Notice of Dissolution of Group
Not Applicable
Item 10 Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and
were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Follow Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)

Page 9 of 10